John M. Evans

CIK: 0001786304

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)19 (52.8%)

Position reduction

Option Exercises (M)13 (36.1%)

Derivative conversions

Awards (A)4 (11.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BEAM

Beam Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (36 total)

BEAM
Beam Therapeutics Inc.
Oct 16, 2026
Sale(S)
Direct
25K shares at avg. $23.98$600K
BEAM
Beam Therapeutics Inc.
Oct 16, 2026
Exercise(M)
Direct
25K shares at avg. $1.03$26K
BEAM
Beam Therapeutics Inc.
Oct 15, 2026
Exercise(M)
Direct
25K shares at avg. $1.03$26K
BEAM
Beam Therapeutics Inc.
Oct 15, 2026
Sale(S)
Direct
25K shares at avg. $23.57$589K
BEAM
Beam Therapeutics Inc.
Jun 30, 2026
Sale(S)
Direct
23.1K shares at avg. $34.26$791K
BEAM
Beam Therapeutics Inc.
Jun 30, 2026
Sale(S)
Direct
1.9K shares at avg. $34.84$66K
BEAM
Beam Therapeutics Inc.
Jun 30, 2026
Exercise(M)
Direct
25K shares at avg. $1.03$26K
BEAM
Beam Therapeutics Inc.
Jun 29, 2026
Exercise(M)
Direct
18.7K shares at avg. $0.67$13K
BEAM
Beam Therapeutics Inc.
Jun 29, 2026
Sale(S)
Direct
11.6K shares at avg. $35.91$416K
BEAM
Beam Therapeutics Inc.
Jun 29, 2026
Sale(S)
Direct
13.4K shares at avg. $35.13$472K
BEAM
Beam Therapeutics Inc.
Jun 29, 2026
Exercise(M)
Direct
6.3K shares at avg. $1.03$7K
BEAM
Beam Therapeutics Inc.
Apr 1, 2026
Sale(S)
Direct
30.1K shares at avg. $24.58$739K
BEAM
Beam Therapeutics Inc.
Mar 31, 2026
Exercise(M)
Direct
25K shares at avg. $0.67$17K
BEAM
Beam Therapeutics Inc.
Mar 31, 2026
Sale(S)
Direct
25K shares at avg. $22.76$569K
BEAM
Beam Therapeutics Inc.
Mar 31, 2026
Award(A)
Direct
90K shares-
BEAM
Beam Therapeutics Inc.
Mar 30, 2026
Sale(S)
Direct
25K shares at avg. $22.37$559K
BEAM
Beam Therapeutics Inc.
Mar 30, 2026
Exercise(M)
Direct
25K shares at avg. $0.67$17K
BEAM
Beam Therapeutics Inc.
Jan 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
180K shares-
BEAM
Beam Therapeutics Inc.
Jan 30, 2026
Sale(S)
Direct
2.9K shares at avg. $29.00$84K
BEAM
Beam Therapeutics Inc.
Jan 30, 2026
Exercise(M)
Direct
25K shares at avg. $0.67$17K
BEAM
Beam Therapeutics Inc.
Jan 30, 2026
Sale(S)
Direct
22.1K shares at avg. $28.27$625K
BEAM
Beam Therapeutics Inc.
Jan 29, 2026
Sale(S)
Direct
8.7K shares at avg. $29.74$258K
BEAM
Beam Therapeutics Inc.
Jan 29, 2026
Sale(S)
Direct
16.3K shares at avg. $29.19$477K
BEAM
Beam Therapeutics Inc.
Jan 29, 2026
Exercise(M)
Direct
19.3K shares at avg. $0.67$13K
BEAM
Beam Therapeutics Inc.
Jan 29, 2026
Exercise(M)
Direct
5.7K shares at avg. $0.67$4K

		Type	Shares	Price		Ownership
Oct 16, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	25,000	$23.98	$599,595	Direct
Oct 16, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	25,000	$1.03	$25,750	Direct
Oct 15, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	25,000	$1.03	$25,750	Direct
Oct 15, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	25,000	$23.57	$589,150	Direct
Jun 30, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	23,100	$34.26	$791,482	Direct
Jun 30, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	1,900	$34.84	$66,203	Direct
Jun 30, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	25,000	$1.03	$25,750	Direct
Jun 29, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	18,663	$0.67	$12,504	Direct
Jun 29, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	11,579	$35.91	$415,824	Direct
Jun 29, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	13,421	$35.13	$471,528	Direct
Jun 29, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	6,337	$1.03	$6,527	Direct
Apr 1, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	30,078	$24.58	$739,317	Direct
Mar 31, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	25,000	$0.67	$16,750	Direct
Mar 31, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	25,000	$22.76	$569,085	Direct
Mar 31, 2026	BEAM Beam Therapeutics Inc.	Award(A)	90,000	-	$0	Direct
Mar 30, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	25,000	$22.37	$559,230	Direct
Mar 30, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	25,000	$0.67	$16,750	Direct
Jan 31, 2026	BEAM Beam Therapeutics Inc.	Award(A) Stock Option (Right to Buy)	180,000	-	-	Direct
Jan 30, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	2,906	$29.00	$84,274	Direct
Jan 30, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	25,000	$0.67	$16,750	Direct
Jan 30, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	22,094	$28.27	$624,672	Direct
Jan 29, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	8,667	$29.74	$257,781	Direct
Jan 29, 2026	BEAM Beam Therapeutics Inc.	Sale(S)	16,333	$29.19	$476,801	Direct
Jan 29, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	19,336	$0.67	$12,955	Direct
Jan 29, 2026	BEAM Beam Therapeutics Inc.	Exercise(M)	5,664	$0.67	$3,795	Direct

1-25 of 36 transactions

About Evans John M.

Evans John M. (SEC CIK 0001786304) files insider reports with the SEC as CEO of Beam Therapeutics Inc. (BEAM).

Signal8 holds 11 ownership filings by Evans John M., all Form 4s, filed between Oct 2, 2024 and Oct 16, 2026. Those filings report 36 transactions, from Sep 30, 2024 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Evans John M.'s filings is in CAMBRIDGE, MA.

Recent filings by Evans John M.

Oct 16, 2026: Open-market sale of BEAM shares (Form 4, code S).
Oct 16, 2026: Option exercise of BEAM shares (Form 4, code M).
Oct 15, 2026: Option exercise of BEAM shares (Form 4, code M).
Oct 15, 2026: Open-market sale of BEAM shares (Form 4, code S).
Jun 30, 2026: Open-market sales of BEAM shares (2 lines, Form 4, code S).

Other insiders filing for Beam Therapeutics Inc. (BEAM)

Cavanagh Bethany J, SVP, Finance and Treasurer
Ciaramella Giuseppe, President
Simon Amy, Chief Medical Officer
FMR LLC, 10% Owner
Shaw Christi, Director
Walsh Kathleen E, Director

How to read Form 4 transaction codes